Oslo Economics, UCB Pharma and the University of Bergen are currently collaborating on a research project about the societal costs of myasthenia in Norway. Christoffer Bugge and Ingrid Engebretsen from Oslo Economics have presented preliminary results from the research project on two different conferences. On September 21st ., Christoffer Bugge and Ingrid Engebretsen presented the study at the yearly conference held by the American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) in Nashville, Tennessee. On October 1st , Ingrid presented the study at the “Living with Myasthenia gravis”-conference in Denmark. The study is financed by UCB Pharma.